Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 6io0.1

Human IDH1 R132C mutant complexed with compound A.

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.20 Å
Oligo State
homo-dimer
Ligands
2 x AOU: (2E)-3-{3-[3-(2,6-dichlorophenyl)-5-(propan-2-yl)-1,2-oxazole-4-carbonyl]-1-methyl-1H-indol-7-yl}prop-2-enoic acid(Non-covalent)
2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
3 x CIT: CITRIC ACID(Non-functional Binders)
7 x GOL: GLYCEROL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Machida, Y. et al., A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model. Mol.Cancer Ther. (2020)
Release Date
2019-10-30
Peptides
Isocitrate dehydrogenase [NADP] cytoplasmic: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Isocitrate dehydrogenase [NADP] cytoplasmic